GSK (LON:GSK – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Citigroup in a research note issued to investors on Monday, Marketbeat Ratings reports. They currently have a GBX 2,100 ($26.64) target price on the stock. Citigroup’s target price would suggest a potential upside of 31.66% from the company’s current price.
A number of other brokerages have also issued reports on GSK. Shore Capital reiterated a “buy” rating on shares of GSK in a report on Wednesday, June 12th. JPMorgan Chase & Co. reiterated an “underweight” rating on shares of GSK in a report on Tuesday, June 18th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 1,950 ($24.74) target price on shares of GSK in a report on Tuesday, June 18th. Finally, Barclays restated an “equal weight” rating and set a GBX 1,725 ($21.88) target price on shares of GSK in a report on Tuesday, May 7th. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, GSK presently has an average rating of “Hold” and an average price target of GBX 1,725.63 ($21.89).
Read Our Latest Research Report on GSK
GSK Stock Down 0.8 %
Insider Activity
In other GSK news, insider Wendy Becker acquired 446 shares of the firm’s stock in a transaction dated Thursday, June 20th. The stock was purchased at an average price of GBX 1,614 ($20.47) per share, for a total transaction of £7,198.44 ($9,131.60). Company insiders own 1.60% of the company’s stock.
About GSK
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.
Read More
- Five stocks we like better than GSK
- Investing In Automotive Stocks
- Chipotle Mexican Grill Stock Split: Where Does it Go From Here?
- Health Care Stocks Explained: Why You Might Want to Invest
- Arm Holdings and Micron: Top 2 AI Stocks to Buy and Hold
- Retail Stocks Investing, Explained
- Best Buy Stock May Be Best Bought Before the Holiday Season
Receive News & Ratings for GSK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GSK and related companies with MarketBeat.com's FREE daily email newsletter.